Cart
sales@molnova.com
Kenpaullone
CAS No. 142273-20-9
Kenpaullone( 9-Bromopaullone | NSC-664704 )
Catalog No. M11777 CAS No. 142273-20-9
Kenpaullone (9-Bromopaullone,NSC-664704) is a potent inhibitor of CDK1/cyclin B with IC50 of 0.4 uM, also inhibited CDK2/cyclin A (IC50=0.68 uM), CDK2/cyclin E (IC50-7.5 uM) and CDK5/p25 (IC50=0.85 uM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 65 | In Stock |
|
| 2MG | 43 | In Stock |
|
| 5MG | 61 | In Stock |
|
| 10MG | 91 | In Stock |
|
| 25MG | 188 | In Stock |
|
| 50MG | 312 | In Stock |
|
| 100MG | 463 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1051 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameKenpaullone
-
NoteResearch use only, not for human use.
-
Brief DescriptionKenpaullone (9-Bromopaullone,NSC-664704) is a potent inhibitor of CDK1/cyclin B with IC50 of 0.4 uM, also inhibited CDK2/cyclin A (IC50=0.68 uM), CDK2/cyclin E (IC50-7.5 uM) and CDK5/p25 (IC50=0.85 uM).
-
DescriptionKenpaullone (9-Bromopaullone,NSC-664704) is a potent inhibitor of CDK1/cyclin B with IC50 of 0.4 uM, also inhibited CDK2/cyclin A (IC50=0.68 uM), CDK2/cyclin E (IC50-7.5 uM) and CDK5/p25 (IC50=0.85 uM); shows less effect on other kinases, only c-Src, CK2, ERK1/2 (IC50=15-20 uM) with IC50s less than 30 uM; displays delayed cell cycle progression in treated cells; also is a potent inhibitor of GSK-3β (IC50=23 nM), activates Nanog expression in mouse fibroblasts transduced with a subset of reprogramming factors lacking Klf4, can replace Klf4 in the reprogramming of primary and secondary fibroblasts and NPCs.
-
In Vitro——
-
In Vivo——
-
Synonyms9-Bromopaullone | NSC-664704
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCDK1/CyclinB|CDK2/CyclinA|CDK2/CyclinE|CDK5/p35|GSK-3β
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number142273-20-9
-
Formula Weight327.1754
-
Molecular FormulaC16H11BrN2O
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 35 mg/mL
-
SMILESO=C(NC1=CC=CC=C12)CC3=C2NC4=C3C=C(Br)C=C4
-
Chemical NameIndolo[3,2-d][1]benzazepin-6(5H)-one, 9-bromo-7,12-dihydro-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zaharevitz DW, et al. Cancer Res. 1999 Jun 1;59(11):2566-9.
2. Schultz C, et al. J Med Chem. 1999 Jul 29;42(15):2909-19.
3. Bain J, et al. Biochem J. 2003 Apr 1;371(Pt 1):199-204.
4. Lyssiotis CA, et al. Proc Natl Acad Sci U S A. 2009 Jun 2;106(22):8912-7.
molnova catalog
related products
-
JNJ-7706621
A dual CDK/Aurora kinase inhibitor with IC50 of 9/4/11/15 nM for CDK1/CDK2/Aurora A/Aurora B respectively; also exhibits activity towards CDK3, CDK4, and CDK6 (IC50s=50-250 nM).
-
Ribociclib succinate
Ribociclib succinate is a highly specific CDK4/6 inhibitor (IC50: 10 nM and 39 nM, respectively). It also is over 1,000-fold less potent against the cyclin B/CDK1 complex.
-
23-epi-26-Deoxyactei...
23-epi-26-Deoxyactein has anti-inflammatory activity, it inhibits nitric oxide production by reducing iNOS expression without affecting activity of the enzyme. It also has anti-cancer activity, it can inhibit growth of the MCF7 human breast cancer cells and induce cell cycle arrest at G1.
